Dr. Renée Deehan is a Senior Vice President, Research and Development, Selventa. Together with her team of biologists and computational biologists, she is responsible for the scientific content behind ClarifyRA, a diagnostic that provides molecular information about Disease Activity and potential response to treatment for Rheumatoid Arthritis patients. Dr. Deehan Kenney also leads the science for Selventa's consulting services, and she leverages her understanding of both the industry and client needs to develop custom strategies that translate scientific challenges into navigable solutions. This is predicated on her fundamental belief that a comprehensive understanding of the molecular basis of disease, at the level of an individual patient, is required for successful target discovery and biomarker development and ultimately for personalized medicine in the clinic. Dr. Deehan Kenney has led over 45 collaborations with pharmaceutical, consumer product, and academic partners. She represents Selventa externally to clients, the Board of Directors and Selventa's Scientific Advisory Board, and she has spoken at personalized medicine conferences across the globe.
Research Interest
Computable, Network model, Tissue repair, Angiogenesis, Bioengineering, Personalized Medicine
+44 1478 350008